CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Unrecognized Tax Benefits, Income Tax Penalties Accrued
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) had Unrecognized Tax Benefits, Income Tax Penalties Accrued of $34.20 million as of 2026-06-27, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Income Taxes › Income Tax Uncertainties › Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued
us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAccrued · last filed 2026-08-05
- 2026-06-27: Unrecognized Tax Benefits, Income Tax Penalties Accrued $34.20M.
- 2026-03-28: Unrecognized Tax Benefits, Income Tax Penalties Accrued $32.70M.
- 2025-12-27: Unrecognized Tax Benefits, Income Tax Penalties Accrued $0.00.
- 2024-12-28: Unrecognized Tax Benefits, Income Tax Penalties Accrued $0.00.
| Period end | Unrecognized Tax Benefits, Income Tax Penalties Accrued |
|---|---|
| 2026-06-27 | $34.20M 10-Q · filed 2026-08-05 |
| 2026-03-28 | $32.70M 10-Q · filed 2026-05-07 |
| 2025-12-27 | $0.00 10-K · filed 2026-02-18 |
| 2024-12-28 | $0.00 10-K · filed 2026-02-18 |
| 2023-12-30 | $0.00 10-K · filed 2025-02-19 |
| 2022-12-31 | $0.00 10-K · filed 2024-02-14 |
| 2021-12-25 | $0.00 10-K · filed 2023-02-22 |
| 2020-12-26 | $0.00 10-K · filed 2022-02-16 |
| 2019-12-28 | $0.00 10-K · filed 2021-02-17 |
| 2018-12-29 | $0.00 10-K · filed 2020-02-11 |
| 2017-12-30 | $300.00K 10-K · filed 2019-02-13 |
| 2016-12-31 | $200.00K 10-K · filed 2018-02-13 |
| 2016-09-24 | $200.00K 10-Q · filed 2016-11-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |